Search clinical trials for: SQ SLIT-tablet

Total 9271 results

ALK-Abelló A/S
Inflamax Research Incorporated

Completed

A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

Allergic Rhinoconjunctivitis

Canada
ALK-Abelló A/S
Quantify Research

Active, not recruiting

Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma

Asthma | Allergy | Allergic Rhinitis

Denmark
ALK-Abelló A/S

Not yet recruiting

A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65

Allergic Rhinitis | Allergic Rhinoconjunctivitis

China
ALK-Abelló A/S

Terminated

A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber (QUEST)

Allergic Rhinoconjunctivitis

Austria, China
Lars Olaf Cardell

Recruiting

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT (ILIT vs SLIT)

Allergic Rhinitis Due to Grass Pollen

Sweden
National Institute of Allergy and Infectious Diseases...
Imperial College London; Immune Tolerance Network (ITN)

Completed

Long-Term Effects of Sublingual Grass Therapy

Rhinitis, Allergic, Seasonal

United Kingdom
Bispebjerg Hospital
Lund University; University of Copenhagen; ALK-Abelló A/S

Completed

The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma (VITAL)

Allergic Asthma Due to Dermatophagoides Pteronyssinus

Denmark
Tasly Pharmaceutical Group Co., Ltd

Completed

Study of Jitongning Tablet to Treat Spondyloarthritis

Spondyloarthritis

China
Stallergenes Greer

Completed

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

Asthma | House Dust Mite Allergy

France, Germany, Poland
ALK-Abelló A/S
Parexel

Completed

A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis (TreeTop)

Allergy

Hungary, Canada, Belgium, Poland, Austria, Germany, Denmark, Lithuania, Netherlands, Russian Federation, Slovakia
Imperial College London
King's College London; Wellcome Trust; ALK-Abelló A/S

Completed

Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study (Pollen+)

Allergic Rhinitis

United Kingdom
ALK-Abelló A/S
Parexel

Active, not recruiting

Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Peanut Allergy

United States, Canada
ALK-Abelló A/S
ITEC Services

Completed

N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France (CARIOCA)

Allergic Rhinitis Due to House Dust Mite | Allergic Asthma Due to Dermatophagoides Farinae | Allergic Asthma Due to Dermatophagoides Pteronyssinus

France
ALK-Abelló A/S
Syneos Health

Completed

Adolescent Mite Allergy Safety Evaluation (AMASE)

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Slovakia, Czechia, Germany
Eli Lilly and Company

Completed

A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Bulgaria, Poland, Moldova, Republic of, Romania
Karolinska Institutet

Recruiting

Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen (NAC)

Allergic Rhinitis Due to Pollen

Sweden
ALK-Abelló A/S

Completed

Mite Asthma Pediatric Immunotherapy Trial (MAPIT)

Allergic Rhinitis Due to House Dust Mite | Allergic Asthma Due to Dermatophagoides Farinae | Allergic Asthma Due to Dermatophagoides Pteronyssinus

Poland, United Kingdom, Spain, United States, Russian Federation, Hungary, France, Bulgaria, Germany
Beijing Tongren Hospital

Completed

Novel Dose Adjustment Schedule for Late Injection in SCIT in AR

Allergic Rhinitis | Immunotherapy

China
Chengdu PLA General Hospital

Unknown

The Effect of Square Dance on Rheumatoid Arthritis

Rheumatoid Arthritis

China
Stallergenes Greer

Completed

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Asthma | House Dust Mite Allergy

France
Novartis Pharmaceuticals

Completed

A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance

Seasonal Allergic Rhinitis

United Kingdom
University of Wisconsin, Madison
National Center for Complementary and Integrative Health (NCCIH)

Completed

Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy

Asthma

United States
ALK-Abelló A/S

Completed

Intraseasonal Short-time Up-dosing With Alutard SQ Grasses

Allergy

Germany
Radboud University Medical Center

Completed

Pharmacology of Insulin Injected With Jet-Injection

Diabetes Mellitus, Type 1

Netherlands
Yiling Pharmaceutical Inc.

Completed

A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China

Parkinson Disease

China
University of California, San Francisco
Centre de Recherche en Sante de Nouna, Burkina Faso

Not yet recruiting

Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition (INSPIRE)

Acute Malnutrition in Childhood | Nutrition Assessment | Malaria Incidence | Seasonal Malaria Chemoprevention | Integrated Community-based Intervention Package | Acute Malnutrition

Burkina Faso
University of Pittsburgh
CSL Behring

Completed

Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement

Infections After Lung Transplant

United States
ALK-Abelló A/S

Completed

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber (AV-G-03)

Grass Pollen Induced Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

Atopic Dermatitis

Germany
Guy's and St Thomas' NHS Foundation Trust

Unknown

The Use of Subcutaneous Implantable Cardiac Defibrillators (ICDs) Following Extraction of Conventional ICDs (SUBTRACT)

Use of Subcutaneous ICDs Following Infection
The National Institutes of Pharmaceutical R&D Co...

Completed

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

Idiopathic Pulmonary Fibrosis

United States
ASST Fatebenefratelli Sacco
ALK-Abelló A/S

Completed

Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy

Pollen Allergy

Italy
Shanghai Shenqi Medical Technology Co., Ltd

Recruiting

Safety and Effectiveness Study of SQ-Kyrin System for Functional Mitral Regurgitation in EU

Functional Mitral Regurgitation

Spain
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects

Nonalcoholic Steatohepatitis (NASH)

China
Shanghai Shenqi Medical Technology Co., Ltd

Active, not recruiting

Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation

Functional Mitral Regurgitation

China
Clinique Spécialisée en Allergies de la Capitale
ALK-Abelló A/S

Completed

Vestibular Versus Sublingual Route of AIT Tablets

Hypersensitivity

Canada
University of North Carolina, Chapel Hill
National Center for Complementary and Integrative Health (NCCIH)

Completed

Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance (SLIT-TLC)

Food Hypersensitivity | Peanut Hypersensitivity | Peanut Allergy | Food Allergy

United States
Shanghai Shenqi Medical Technology Co., Ltd

Active, not recruiting

SQ-Kyrin-T First-in-man Feasibility Study

Tricuspid Regurgitation

China
Atridia Pty Ltd.

Completed

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

Inflammatory Bowel Disease

Australia
Assiut University

Unknown

Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus

Lens Diseases
Assiut University

Unknown

Patients' Satisfaction After LASIK

Refractive Errors
Lexicon Pharmaceuticals

Completed

A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Harmony Biosciences, LLC

Active, not recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension

Prader-Willi Syndrome

United States
University of Zurich

Not yet recruiting

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

Allergic Rhinitis | Allergic Asthma

Switzerland
Shanghai Shenqi Medical Technology Co., Ltd

Recruiting

SQ-Kyrin TMVr FIM Study

Mitral Regurgitation

China
Cairo University

Completed

Ocular Findings in Women With Primary Antiphospholipid Syndrome

Primary Antiphospholipid Syndrome

Egypt
Zhejiang Wenda Medical Technology Co., Ltd.

Not yet recruiting

A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants

Healthy Participants

Australia
Paratek Pharmaceuticals Inc

Completed

Oral Omadacycline Vs. Placebo in Adults with NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Mycobacterium Infections, Nontuberculous | Nontuberculous Mycobacterial Lung Disease | Mycobacterium Abscessus Infection | Nontuberculous Mycobacterial Pulmonary Infection

United States
Rigshospitalet, Denmark

Completed

The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.

Hyponatremia | Metabolic Bone Disease

Denmark
Dong Wha Pharmaceutical Co. Ltd.

Completed

The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

Diabetic Kidney Disease

Korea, Republic of

Search clinical trials for: SQ SLIT-tablet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations